Clinical Trials Browser

OTHER × Colonic Neoplasms × toripalimab × Clear all

NCT07140679 2025-09-25

Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

NCT03985891 2020-12-17

JSFOL

Phase 1/2 Unknown

Gastrointestinal

Colonic Neoplasms